openPR Logo
Press release

Antiviral Drugs Market Features of Investment Opportunities, Market Share & Future Trends to 2026 | Gilead Sciences, F. Hoffmann-La Roche AG, GlaxoSmithKline, and more

03-30-2020 01:27 PM CET | Business, Economy, Finances, Banking & Insurance

Press release from: Reports And Data

Antiviral Drugs Market

Antiviral Drugs Market

Market Size - USD 49.87 Billion in 2018, Market Growth - CAGR of 4.6%, Market Trends - Product launches along with effective R&D

According to the current analysis of Reports and Data, the global antiviral drugs market was valued at USD 49.87 billion in 2018 and is expected to reach USD 71.48 billion by year 2026, at a CAGR of 4.6%. Antiviral drugs help to diminish the duration of flu symptoms in otherwise healthy children and adults and may lessen the severity of common flu symptoms. Antiviral drugs are medicines that reduce the intensity of flu viruses to reproduce.

To get a sample pdf with the skeleton of the Global Antiviral Drugs Market Report, click here: https://www.reportsanddata.com/sample-enquiry-form/1734

Key market players in the global antiviral drugs market include, Gilead Sciences, F. Hoffmann-La Roche AG, GlaxoSmithKline, Bristol-Myers-Squibb, AbbVie, Johnson & Johnson, Merck & Co., Aurobindo Pharma, Cipla, and Dr Reddy's

For the purpose of this study, Reports and Data have segmented the Global Antiviral Drugs market on the basis of type, application, mechanism of action and region:

Type (Revenue, USD Million; 2016-2026)
Branded
Generic

Application (Revenue, USD Million; 2016-2026)
HIV
Hepatitis
Herpes Simplex Virus
Influenza
Others

Mechanism of Action (Revenue, USD Million; 2016-2026)
Reverse transcriptase inhibitors
Nucleotide polymerase inhibitors
Protease inhibitors
Others

Regional Outlook (Revenue in USD Million; 2016-2026)
North America
Europe
Rest of the Europe
Asia Pacific
Middle East & Africa
Latin America

To avail this report at great discount rates, click here @ https://www.reportsanddata.com/discount-enquiry-form/1734

Most antivirals are used for specific viral infections, while a broad-spectrum antiviral is effective against a wide range of viruses. Antiviral drugs are suggested for both treatment and prevention of flu. Antiviral drugs work best when consumed within 48 hours of beginning of flu symptoms, but they may still offer benefits when taken later depending upon the nature of the flu. They may also reduce the risk of complications such as ear infections in children, respiratory complications requiring antibiotics, and hospitalization in adults. Viruses use the host's cells to replicate thus, creating a safe and effective antiviral drug is tough.

Rising incidences of viral infection along with increase in public awareness, rise in healthcare expenditure, effective investments on R&D and development of severe and life-threatening diseases is likely to foster the growth of the global antiviral drugs market. Furthermore, Huge target population is provided by increasing frequency of STIs caused by human immunodeficiency virus and human papillomavirus.

Further key findings from the report suggest

Growing incidences of HIV is likely to create higher demand for global antiviral drugs market. According to the statistics estimated by World Health Organization, around 70 million people have been infected with the HIV virus and about 35 million people have died of HIV

Owing to the introduction of new and solid drugs along with effective R&D practices, hepatitis registered as the fastest growing segment in the applications with highest compounded annual growth rate of 5.3%

North America held a market share of 35.1% in the year 2018. High level of R&D in the region makes North America to have chief market share in the market

Complications of influenza, and other illnesses that resemble influenza, may require different treatment and in some cases, urgent medical attention which prescribes antiviral drugs for curation. Influenza viruses can become resistant to specific anti-influenza antiviral drugs, and all of these drugs may have side effects

HIV segment in the applications is likely to hold the highest market share during the forecast period due to growing incidences of HIV infections across the globe. HIV held a market share of roughly, 49.1% in the year 2018

Asia-Pacific regions registers the fastest growth in the antiviral drugs market with highest CAGR of 5.5%. Rising awareness regarding HIV and initiatives taken by the governments in the region to encourage the treatment of the disease will fuel the market growth in APAC

Owing to the introduction of new and solid drugs along with effective R&D practices, hepatitis registered as the fastest growing segment in the applications with highest compounded annual growth rate of 5.3%

North America held a market share of 35.1% in the year 2018. High level of R&D in the region makes North America to have chief market share in the market

Branded drugs segment dominated the antiviral drugs market with a market share of approximately, 53.2% due to availability of wide range of products along with high prescription rate

Find the extensive Report Description, TOC and Table of Figure @ https://www.reportsanddata.com/report-detail/antiviral-drugs-market

Major selling points of this research report

Gives the reader a holistic comprehension of the global market
Identifies the recent trends and estimated growth rate for the forecast duration
Helps industry experts, investors, and other participants implement lucrative expansion approaches
Provides accurate market insights to take informed decisions through presentations and other tools
Outlines the competitive landscapes with the individual market share of top vendors

Contact Us:
Reports And Data
40 Wall St. 28th floor New York City, NY 10005 United States
Direct Line: +1-212-710-1370
E-mail: sales@reportsanddata.com

About Us:
Reports and Data is a market research and consulting company that provides syndicated research reports, customized research reports, and consulting services. Our solutions purely focus on your purpose to locate, target and analyze consumer behavior shifts across demographics, across industries and help client's make a smarter business decision. We offer market intelligence studies ensuring relevant and fact-based research across a multiple industries including Healthcare, Technology, Chemicals, Power and Energy. We consistently update our research offerings to ensure our clients are aware about the latest trends existent in the market.

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Antiviral Drugs Market Features of Investment Opportunities, Market Share & Future Trends to 2026 | Gilead Sciences, F. Hoffmann-La Roche AG, GlaxoSmithKline, and more here

News-ID: 1990282 • Views:

More Releases from Reports And Data

Point Of Sale (POS) Software Market Insights into the Evolving Landscape of 2032
Point Of Sale (POS) Software Market Insights into the Evolving Landscape of 2032
The latest report by Reports and Data on the global Point Of Sale (POS) Software Market. The report highlights the growing demand for APPLICATION POS software due to the increasing popularity of digital payment solutions and the shift towards cashless purchases accelerated by the COVID-19 pandemic. APPLICATION POS software enables secure and efficient transactions, making it highly sought-after by businesses and customers alike. In addition to facilitating transactions, APPLICATION POS software
Radio Persistence Coaxial Connector (RPC) Market Connecting the World A Look into the Booming 2032
Radio Persistence Coaxial Connector (RPC) Market Connecting the World A Look int …
The Global Radio Persistence Coaxial Connector (RPC) market The increasing demand for wireless communication systems and expanding usage of RPCs across various industries such as telecommunications, aerospace, defense, medical, and automotive, is driving the growth of the market. RPCs are widely used in communication devices, antennas, and other electronic equipment that require high-speed data transfer and dependable connectivity. The projected revenue CAGR of 7.2% during the forecast period indicates a positive
Point Of Sale (POS) Software Market Segmentation and Growth Opportunities in Retail Industry Transformation 2032
Point Of Sale (POS) Software Market Segmentation and Growth Opportunities in Ret …
The latest report by Reports and Data on the global Point Of Sale (POS) Software Market. The report highlights the growing demand for APPLICATION POS software due to the increasing popularity of digital payment solutions and the shift towards cashless purchases accelerated by the COVID-19 pandemic. APPLICATION POS software enables secure and efficient transactions, making it highly sought-after by businesses and customers alike. In addition to facilitating transactions, APPLICATION POS software
Drone Analytics Market The Growing Importance of Drone Analytics in Agriculture 2032
Drone Analytics Market The Growing Importance of Drone Analytics in Agriculture …
  Demand for actionable insights from drone data is driving market revenue growth in a range of industries, including agriculture, construction, mining, and oil & gas. Drones have increased in popularity in recent years due to their ability to capture massive volumes of data more rapidly and inexpensively than traditional methods. The global drone analytics market size was USD 3.93 Billion in 2022 and is expected to register a revenue CAGR of 31% over

All 5 Releases


More Releases for Antiviral

Antiviral Drugs Market Size, Report 2022-2030
Acumen Research and Consulting has announced the addition of the "Antiviral Drugs Market" report to their offering. The Antiviral Drugs Market Report 2030 is an in depth study analyzing the current state of the Antiviral Drugs Market. It provides brief overview of the market focusing on definitions, market segmentation, end-use applications and industry chain analysis. The study on Antiviral Drugs Market provides analysis of global market covering the industry trends, recent
Antiviral Drugs Market
“Antiviral Drugs Market” study by “The Insight Partners” provides details about the market dynamics affecting the market, Market scope, Market segmentation and overlays shadow upon the leading market players highlighting the favorable competitive landscape and trends prevailing over the years. This Report encloses comprehensive analysis on the market and are assessed through volume and value data validated on three approaches including top companies revenues. It concludes with precise and authentic market
Antiviral therapies Market: High Cost of Antiviral therapies Is a Major Restrain …
Post COVID-19 Impact on Antiviral Therapies Market –With the emergence of the COVID-19 crisis, the world is fighting a health pandemic as well as an economic emergency, almost impacting trillions of dollars of revenues. Research Dive’ group of skilled analysts provide a solution to help the companies to survive and sustain in this economic crisis. We support companies to make informed decisions based on our findings resulting from the comprehensive
Increasing Utilization of Antiviral Drugs, During the COVID-19 Outbreak, to Prom …
According to antiviral therapies market analysis by Research Dive, the global market forecast will surpass $66,016.5 million in 2027, growing at a 3.1% CAGR from $51,913.1 million in the year2019. Antiviral Therapies Market, COVID-19 Impact: The global antiviral therapies market has responded positively to the pandemic owing to rise in the utilization of antiviral drugs in the development of effective medicines for the COVID-19 treatment. In addition, leading players in the global
Coronavirus's Impact On Antiviral Packaging Market
Antiviral Packaging Market – An Overview The coronavirus pandemic keeps on revamping the idea of worldwide society in 2020, and with it changes the perspectives and practices of buyers now and for a long time to come. In any case, the prompt effect on buyers’ interests about viral introduction and questions hanging about the infection’s capacity to make due on surfaces, may fuel an any longer enduring interest for new bundling
Magniflex Introduces Antiviral and Antibacterial Collection
Magniflex, the renowned mattress manufacturer from Italy, has always had innovation in its DNA, as the success, accolades, and certifications obtained over the years prove, and the goal has always been to introduce innovative solutions to common issues that affect the quality of our sleep. As a response to the COVID-19 global pandemic, Magniflex conducted scientific and technological research in collaboration with prominent experts in order to produce MagniProtect: an